Introduction
Methods
Subjects
Study design and protocol
Endothelium-dependent and -independent vasodilation in the brachial artery
Renal resistive index
Arterial tonometry
Humoral parameters of renin-angiotensin and neurohormonal system
Urinary 8-isoprostanes
Statistical analysis
Results
Dapagliflozin (n = 16) | Hydrochlorothiazide (n = 10) | p value (time × treatment interaction) | |||
---|---|---|---|---|---|
Visit 0 | Visit 1 | Visit 0 | Visit 1 | ||
Plasma glucose (mmol/l) | 7.96 ± 2.47 | 7.43 ± 2.1b
| 6.47 ± 1.16 (n = 6) | 5.32 ± 0.88 (n = 6) | 0.42 |
Haematocrit (%) | 43.0 ± 2.7b
| 42.6 ± 3.1b
| 40.7 ± 4.1 | 40.4 ± 2.4 | 0.52 |
Total cholesterol (mmol/l) | 4.62 ± 0.76 | 4.72 ± 1.09b
| 4.18 ± 0.59 | 3.87 ± 0.50 | 0.17 |
HDL cholesterol (mmol/l) | 1.19 ± 0.23 | 1.24 ± 0.36 | 1.37 ± 0.24 | 1.29 ± 0.16 | 0.30 |
Triglycerides (mmol/l) | 1.40 ± 0.55 | 1.50 ± 0.81 | 1.45 ± 0.31 | 1.16 ± 0.29 | 0.11 |
eGFR (ml/min/1.73 m2) | 95.7 ± 12.8 | 93.7 ± 12.6 | 102.2 ± 6.1 | 97.8 ± 3.9 | 0.51 |
s-sodium (mEq/l) | 141.0 ± 2.0 | 141.1 ± 1.2 | 139.3 ± 1.9 | 141.0 ± 2.6 | 0.13 |
s-potassium (mEq/l) | 4.4 ± 0.3 | 4.3 ± 0.3 | 4.5 ± 2.1 | 4.2 ± 0.4 | 0.61 |
s-calcium (mg/dl) | 9.6 ± 0.2 | 9.6 ± 0.3 | 9.5 ± 0.9 | 9.7 ± 0.9 | 0.03 |
s-chloride (mEq/l) | 101.3 ± 2.9 | 100.3 ± 2.1 | 101.3 ± 2.9 | 102.0 ± 0.0 | 0.17 |
s-magnesium (mg/dl) | 1.92 ± 0.19 | 2.04 ± 0.17ab
| 1.98 ± 0.33 | 1.90 ± 0.27 | 0.003 |
s-osmolarity (mOsm/l) | 296 ± 5b
| 296 ± 2 | 290 ± 5 | 294 ± 7 | 0.04 |
Plasma renin activity (ng/ml/h) | 0.50 ± 0.33 | 1.13 ± 0.97ab
| 1.09 ± 0.56 | 4.00 ± 0.06a
| 0.001 |
Aldosterone (pg/ml) | 12.0 ± 4.7 | 14.3 ± 7.0 | 7.4 ± 4.6 | 3.9 ± 0.3 | 0.36 |
Norepinephrine (nmol/l) | 414 [175]b
| 424 [73] | 517 [419] | 473 [413]a
| 0.18 |
Adrenaline (pmol/l) | 25 [37] | 25 [24] | 41 [13] | 40 [11] | 0.86 |
Dapagliflozin (n = 16) | Hydrochlorothiazide (n = 10) | p value (time × treatment interaction) | |||
---|---|---|---|---|---|
Visit 0 | Visit 1 | Visit 0 | Visit 1 | ||
Diuresis (ml/24 h) | 1400 [750] | 2000 [750]a
| 1250 [150] | 2100 [700] | 0.47 |
u-sodium (mEq/24 h) | 175 [107] | 180 [57] | 129 [96] | 141 [173] | 0.31 |
u-potassium (mEq/24 h) | 60 [37] | 64 [36] | 56 [23] | 59 [49] | 0.10 |
u-calcium (mg/24 h) | 220 [238] | 158 [229] | 250 [120] | 93 [260] | 0.47 |
u-chloride (mEq/24 h) | 183 [113] | 167 [79] | 105 [121] | 130 [163] | 0.30 |
u-magnesium (mg/24 h) | 70 [86] | 72 [88] | 100 [36] | 78 [103] | 0.34 |
u-osmolarity (mOsm/l) | 687 ± 325 | 877 ± 230b
| 512 ± 76 | 377 ± 179 | 0.15 |
Glycosuria (mg/24 h) | 406 [4224] | 70,630 [40,110]ab
| 100 [84] | 45 [135] | < 0.001 |
Osmolar clearance (ml/24 h) | 2369 [3509] | 5971 [3251]a
| 1982 [664] | 2063 [2922] | 0.28 |
Free water clearance (ml/24 h) | − 1119 [3441] | − 4221 [3549]a
| − 757 [538] | 36 [2222] | 0.17 |
Na fractional excretion | 0.89 ± 0.32 | 0.97 ± 0.34 | 0.62 ± 0.17 | 0.79 ± 0.07 | 0.72 |
Dapagliflozin (n = 16) | Hydrochlorothiazide (n = 10) | p value (time × treatment interaction) | |||
---|---|---|---|---|---|
Visit 0 | Visit 1 | Visit 0 | Visit 1 | ||
Office systolic BP (mmHg) | 130.6 ± 12.8 | 125.4 ± 11.2 | 137.2 ± 12.6 | 128.8 ± 11.2a
| 0.44 |
Office diastolic BP (mmHg) | 75.3 ± 6.3 | 74.1 ± 6.9 | 76.1 ± 9.2 | 69.2 ± 7.3 | 0.06 |
Office pulse pressure (mmHg) | 55.3 ± 11.2 | 51.3 ± 12.1 | 61.1 ± 10.4 | 59.6 ± 10.5 | 0.45 |
Pulse wave velocity (m/s) dir*0.8 | 10.1 ± 1.6 | 8.8 ± 1.6ab
| 11.0 ± 2.8 | 11.1 ± 2.6 | 0.03 |
Augmentation index (%) | 30.2 ± 9.3 | 29.3 ± 11.2b
| 26.2 ± 5.3 | 22.1 ± 6.6 | 0.22 |
Augmentation index@75 (%) | 26.3 ± 7.5 | 24.8 ± 10.1b
| 22.4 ± 5.8 | 19.6 ± 5.1 | 0.58 |
Central systolic BP (mmHg) | 119.7 ± 10.6 | 116.0 ± 10.7 | 125.5 ± 11.1 | 115.2 ± 11.5 | 0.17 |
Central pulse pressure (mmHg) | 44.2 ± 8.2 | 40.8 ± 11.5 | 48.4 ± 9.5 | 45.0 ± 10.3 | 0.99 |
Mean BP (mmHg) | 94.4 ± 7.8 | 92.5 ± 6.6 | 97.5 ± 9.2 | 89.5 ± 7.5 | 0.11 |
Augmented pressure (mmHg) | 13.6 ± 6.1 | 12.6 ± 7.5 | 12.8 ± 4.9 | 10.5 ± 5.1 | 0.44 |
Heart rate (bpm) | 67.0 ± 12.0 | 65.5 ± 11.7b
| 67.1 ± 8.7 | 69.8 ± 9.3 | 0.04 |
Brachial artery diameter (mm) | 4.29 ± 0.88b
| 4.46 ± 1.07a
| 4.52 ± 0.54 | 4.49 ± 0.51 | 0.03 |
Flow-mediated dilation (%) | 2.81 ± 2.25 | 4.02 ± 2.09ab
| 2.99 ± 0.91 | 2.63 ± 1.01 | 0.02 |
Baseline shear rate (s−1) | 199 ± 78b
| 140 ± 66a
| 279 ± 108 | 301 ± 118 | < 0.001 |
Hyperemic shear rate (s−1) | 787 ± 292 | 536 ± 337ab
| 927 ± 299 | 889 ± 399 | 0.05 |
Response to GTN (%) | 6.36 ± 3.48 | 6.16 ± 2.87 | 4.11 ± 2.83 | 3.58 ± 2.89 | 0.85 |
Renal resistive index | 0.62 ± 0.04 | 0.59 ± 0.05a
| 0.62 ± 0.05 | 0.62 ± 0.04 | 0.04 |
Dynamic renal resistive index (%) | − 6.10 ± 3.70 | − 2.27 ± 4.39 | − 2.96 ± 3.94 | − 0.91 ± 3.8 | 0.43 |